C07D 319/22
Condensed with one naphthalene or hydrogenated naphthalene ring system
Official title: condensed with one naphthalene or hydrogenated naphthalene ring system
C07D319/22 (Condensed with one naphthalene or hydrogenated naphthalene ring system) appears on 49 US grants and 8 published applications in this corpus.
Search patents in C07D- Granted patents
- 49
- Published applications
- 8
- Assignees
- 18
- Inventors
- 69
- Latest grant
- 1 Oct 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 7 | 0 |
| 1978 | 23 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 3 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use1 Oct 2019US 10,428,017 B2AbbVie S.á.r.l.
- Palladium/silver co-catalyzed tandem reactions synthesis of phenylacetophenone derivatives by oxabenzonorbornadienes with terminal alkynes and their anti-tumor or anti-cancer activities10 Oct 2017US 9,783,519 B2Hong Kong Baptist University
- Co-therapy for the treatment of epilepsy and related disorders7 Oct 2014US 8,853,263 B2Janssen Pharmaceutica NV
- Process for the preparation of 2,2,3,3-tetrafluoro-1,4-benzodioxanes, novel o-(2-bromo-1,1,2,2-tetrafluoroethoxy)-phenols, and novel 2-bromo-1,1,2,2-tetrafluoroethoxy-containing phenyl ethers10 Aug 1999US 5,936,102 ABayer Aktiengesellschaft
- Lignan analogues, methods of preparation thereof and anti-hyperlipemic agents24 Mar 1998US 5,731,455 AShionogi & Co., Ltd.
- Novel quinizarin derivative and preparation method thereof16 Jan 2025US 2025/0019335 A1BenoBio Co., Ltd
- Tricyclic compound, and preparation method therefor and medical use thereof26 Jan 2023US 2023/0021669 A1The National Institutes of Pharmaceutical R&D Co., Ltd.
- Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use30 Aug 2018US 2018/0244611 A1AbbVie S.á.r.l.
- Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use30 Aug 2018US 2018/0244640 A1AbbVie S.á.r.l.
- Reversibly reducible materials and use thereof12 Apr 2018US 2018/0099917 A1University of Kentucky Research Foundation
Most cited
By later US patents
- N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof61US 4,018,915 AMitsubishi Chemical Industries Limited · 1977
- N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof59US 4,018,913 AMitsubishi Chemical Industries Limited · 1977
- N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof52US 4,055,636 AMitsubishi Chemical Industries Limited · 1977
- N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof51US 4,036,955 AMitsubishi Chemical Industries Limited · 1977
- N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof51US 4,041,156 AMitsubishi Chemical Industries Limited · 1977